Medications
Show
- Medications
- Sept. 2020 Executive Order To Lower Drug Prices
- According to a report published in JAMA between 2000 - 2018 the big 35 pharma received a combined revenue of $11.5 trillion with a gross profit of $8.6 trillion
- 314 0
- Musculoskeletal
- Rapamycin May Suppress Muscle Aging & Prevent Sarcopenia
- "Contrary to our expectations, the long-term mTORC1 suppression with rapamycin is overwhelmingly beneficial for skeletal muscle aging..."
- 1190 0
- Drug Trends
- Common Drugs Linked To Increased Risk Of Memory & Thinking Problems
- A recent report published in the journal Neurology has found that taking a class of drugs may increase the risk of developing mild thinking problems
- 1443 0
- Clinical Research Abstracts
- Report Suggests That Only 1 in 10 Treatments Are Backed By Quality Evidence
- "Updated systematic reviews continued to suggest that only a minority of outcomes for health care interventions are supported by high-quality evidence."
- 696 0
-
- Medications
- Sept. 2020 Executive Order To Lower Drug Prices
- According to a report published in JAMA between 2000 - 2018 the big 35 pharma received a combined revenue of $11.5 trillion with a gross profit of $8.6 trillion
- 314 0
-
- Musculoskeletal
- Rapamycin May Suppress Muscle Aging & Prevent Sarcopenia
- "Contrary to our expectations, the long-term mTORC1 suppression with rapamycin is overwhelmingly beneficial for skeletal muscle aging..."
- 1190 0
-
- Drug Trends
- Common Drugs Linked To Increased Risk Of Memory & Thinking Problems
- A recent report published in the journal Neurology has found that taking a class of drugs may increase the risk of developing mild thinking problems
- 1443 0
-
- Clinical Research Abstracts
- Report Suggests That Only 1 in 10 Treatments Are Backed By Quality Evidence
- "Updated systematic reviews continued to suggest that only a minority of outcomes for health care interventions are supported by high-quality evidence."
- 696 0
Load More
